Merck (MRK) Tops Q3 EPS by 31c, Revenues Beat; Narrows & Raises FY20 Non-GAAP EPS Guidance Above Consensus, Provides FY20 Revs. Outlook

Go back to Merck (MRK) Tops Q3 EPS by 31c, Revenues Beat; Narrows & Raises FY20 Non-GAAP EPS Guidance Above Consensus, Provides FY20 Revs. Outlook
Merck & Co. (NYSE: MRK) Delayed: 144.91 --0 (-0%)
Previous Close $144.91    52 Week High $65.46 
Open $144.91    52 Week Low $47.97 
Day High $144.91    P/E 98.58 
Day Low $144.91    EPS $1.47 
Volume 12,484